Measuring tobacco dependence treatment outcomes: A perspective from the behavior change consortium
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The Behavior Change Consortium (BCC) served as a consortium of 15 National Institutes of Health-funded trials intended to link theories of health behavior change to outcomes related to improved diet, exercise, and/or tobacco cessation. Five sites developed and tested interventions aimed at changing tobacco use behaviors, and the remaining 10 focused on changing diet and/or physical activity. The BCC’s tobacco dependence workgroup functioned to identify measures of tobacco use and dependence for use across the 15 BCC trials. The BCC tobacco intervention trials described herein were categorized by type of trial; theory(ies) on which each was based; and the “thickness,” or intensity, of the intervention. Between-site differences across these parameters posed conceptual and analytic challenges for combining data for cross-site analyses, which were integral to the BCC mission of identifying mechanisms of health behavior change. The lessons learned by the BCC tobacco dependence workgroup regarding the measurement and analysis of tobacco outcomes among BCC trials are discussed, including the challenges and the opportunities regarding the preparation for cross-site analyses. The workgroup concludes that trials should report both assessment of a prolonged period of abstinence of 6 months or longer, in addition to the traditional 7-day point prevalence outcome.
This project was supported in part by Grants R01-MH5954 (Geoffrey Williams), cofunded by the National Institute of Mental Health and National Cancer Institute (NCI); R01-CA8069601 (Victor Strecher), funded by NCI; and R01-62165 (Belinda Borrelli), funded by the National Heart, Lung, and Blood Institute.
Solomon S, Kington R: National efforts to promote behavior-change research: views from the Office of Behavioral and Social Sciences Research.Health Education Research. 2002,175:495–499.CrossRef
Hughes JR, Keely JP, Niaura RS, et al.: Measures of abstinence in clinical trials: issues and recommendations.Nicotine & Tobacco Research. 2003,5:13–25.
Zeise L, Dunn A (eds):Health Effects of Exposure to Environmental Tobacco Smoke, Smoking and Tobacco Control Monograph No. 10.Washington, DC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1999.
U.S. Department of Health & Human Services:The Benefits of Smoking Cessation: A Report from the Surgeons General, DHHS Publication No. (CDC) 90-8416. Atlanta, GA: U.S. Department of Human Services, Public Health Service, Centers for Disease, Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990.
Fiore MC, Bailey WC, Cohen SJ, et al.:Treating Tobacco Use and Dependence. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, 2000.
DiClemente CC, Prochaska JO, Fairhurst SK, et al.: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change.Journal of Consulting & Clinical Psychology. 1991,59:295–304.CrossRef
SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation.Nicotine & Tobacco Research. 2002,4:149–159.CrossRef
Pierce JP, Gilpin EA: A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials.Nicotine & Tobacco Research. 2003,5:151–153.CrossRef
Hall SM, Delucchi KL, Velicer WF, et al.: Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcome.Nicotine & Tobacco Research. 2001,3:193–202.CrossRef
U.S. Department of Health and Human Services:Healthy People 2010 (Conference Ed.).Washington, DC: U.S. Government Printing Office, 2000.
Bollen KA:Structural Equations With Latent Variables. New York: Wiley, 1989.
Kline RB:Principles and Practice of Structural Equation Modeling. New York: Guilford, 1998.
Byrne BM: Structural Equation ModelingWith AMOS: Basic Concepts, Applications, and Programming. Mahwah, NJ: Lawrence Erlbaum Associates, Inc., 2001.
Burns DM, Garfinkel L, Samet JM (eds):Changes in Cigarette- Related Disease Risks and Their Implication for Prevention and Control, Smoking and Tobacco Control Monograph No. 8.Washington, DC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1997.
Frosch DL, Stein JA, Shoptaw S: Using latent-variable models to analyze smoking cessation clinical trial data: An example among the methadone maintained.Experimental & Clinical Psychopharmacology. 2002,10:258–267.CrossRef
Williams GC, McGregor HA, Sharp D, et al.: Testing a Self-Determination Theory intervention for motivating tobacco cessation: Supporting autonomy and competence in a clinical trial. Manuscript submitted for publication.
Watson D, Clark LA, Tellegen A: Development and validation of brief measures of positive and negative affect: The PANAS scales.Journal of Personality & Social Psychology. 1988,54:1063–1070.CrossRef
Centers for Disease Control and Prevention:Measuring Health Days. Atlanta, GA: Centers for Disease Control, 2000.
Behavior Change Consortium: Summary report. 2003 Sep, 41–62. Retrieved January 15, 2004, from http://www1.od.nih. gov/behaviorchange
Bellg AJ, Borrelli B, Resnick B, et al.: Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the Behavior Change Consortium.Health Psychology (in press, 2004).
Borrelli B, Resnick B, Bellg AJ, et al.: Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the Behavior Change Consortium. Seminar at the Annual Meeting of the Society of Behavioral Medicine, Washington, DC: 2002.
Borrelli B, Resnick B, Bellg AJ, et al.: Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the Behavior Change Consortium. Seminar at the Annual Meeting of the Society of Behavioral Medicine, Salt Lake City, UT: 2003.
- Measuring tobacco dependence treatment outcomes: A perspective from the behavior change consortium
Annals of Behavioral Medicine
Volume 29, Issue 2 , pp 11-19
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Clinical & Social Sciences in Psychology, University of Rochester, Box 270266, 14627-0266, Rochester, NY, 14627-0266
- 2. Brown Medical School & The Miriam Hospital, Center for Behavioral and Preventive Medicine, USA
- 3. Pacific Telehealth & Technology Hui, USA
- 4. University of Michigan School of Public Health, USA